These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24561451)

  • 1. Polymorphisms and haplotypes of the UDP-glucuronosyltransferase 2B7 gene promoter.
    Hu DG; Meech R; Lu L; McKinnon RA; Mackenzie PI
    Drug Metab Dispos; 2014 May; 42(5):854-62. PubMed ID: 24561451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haplotype analysis of UDP-glucuronocyltransferase 2B7 gene (UGT2B7) polymorphisms in healthy Japanese subjects.
    Saito K; Moriya H; Sawaguchi T; Hayakawa T; Nakahara S; Goto A; Arimura Y; Imai K; Kurosawa N; Owada E; Miyamoto A
    Clin Biochem; 2006 Mar; 39(3):303-8. PubMed ID: 16466707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients.
    Holthe M; Rakvåg TN; Klepstad P; Idle JR; Kaasa S; Krokan HE; Skorpen F
    Pharmacogenomics J; 2003; 3(1):17-26. PubMed ID: 12629580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variations in UDP-glucuronosyltransferase 2B7 gene (UGT2B7) in a Korean population.
    Hwang MS; Lee SJ; Jeong HE; Lee S; Yoo MA; Shin JG
    Drug Metab Pharmacokinet; 2010; 25(4):398-402. PubMed ID: 20814162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel functional polymorphism in the uridine diphosphate-glucuronosyltransferase 2B7 promoter with significant impact on promoter activity.
    Duguay Y; Báár C; Skorpen F; Guillemette C
    Clin Pharmacol Ther; 2004 Mar; 75(3):223-33. PubMed ID: 15001974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene.
    Innocenti F; Liu W; Fackenthal D; Ramírez J; Chen P; Ye X; Wu X; Zhang W; Mirkov S; Das S; Cook E; Ratain MJ
    Pharmacogenet Genomics; 2008 Aug; 18(8):683-97. PubMed ID: 18622261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms in the 5'-flanking region of human UDP-glucuronosyltransferase 2B7 affect the Nrf2-dependent transcriptional regulation.
    Nakamura A; Nakajima M; Higashi E; Yamanaka H; Yokoi T
    Pharmacogenet Genomics; 2008 Aug; 18(8):709-20. PubMed ID: 18622263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octamer transcription factor-1 enhances hepatic nuclear factor-1alpha-mediated activation of the human UDP glucuronosyltransferase 2B7 promoter.
    Ishii Y; Hansen AJ; Mackenzie PI
    Mol Pharmacol; 2000 May; 57(5):940-7. PubMed ID: 10779377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between common polymorphisms in UGT1A9 and gene expression and activity.
    Ramírez J; Liu W; Mirkov S; Desai AA; Chen P; Das S; Innocenti F; Ratain MJ
    Drug Metab Dispos; 2007 Dec; 35(12):2149-53. PubMed ID: 17761781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single nucleotide polymorphisms and haplotype frequencies of UGT2B4 and UGT2B7 in a Japanese population.
    Saeki M; Saito Y; Jinno H; Tanaka-Kagawa T; Ohno A; Ozawa S; Ueno K; Kamakura S; Kamatani N; Komamura K; Kitakaze M; Sawada J
    Drug Metab Dispos; 2004 Sep; 32(9):1048-54. PubMed ID: 15319348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: I. Identification of polymorphisms in the 5'-regulatory and exon 1 regions, and association with human liver UGT1A6 gene expression and glucuronidation.
    Krishnaswamy S; Hao Q; Al-Rohaimi A; Hesse LM; von Moltke LL; Greenblatt DJ; Court MH
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1331-9. PubMed ID: 15761114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups.
    Innocenti F; Grimsley C; Das S; Ramírez J; Cheng C; Kuttab-Boulos H; Ratain MJ; Di Rienzo A
    Pharmacogenetics; 2002 Dec; 12(9):725-33. PubMed ID: 12464801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing the effect of UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A9 genetic polymorphisms on enantioselective glucuronidation of flurbiprofen.
    Wang H; Yuan L; Zeng S
    Biochem Pharmacol; 2011 Dec; 82(11):1757-63. PubMed ID: 21856293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a type 1 diabetes-associated CD4 promoter haplotype with high constitutive activity.
    Kristiansen OP; Karlsen AE; Larsen ZM; Johannesen J; Pociot F; Mandrup-Poulsen T;
    Scand J Immunol; 2004 Jun; 59(6):582-91. PubMed ID: 15182254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variability, haplotypes, and htSNPs for exons 1 at the human UGT1A locus.
    Thomas SS; Li SS; Lampe JW; Potter JD; Bigler J
    Hum Mutat; 2006 Jul; 27(7):717. PubMed ID: 16786511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and expression analysis of SNPs in the human deoxyribonuclease II: SNPs in the promoter region reduce its in vivo activity through decreased promoter activity.
    Kimura-Kataoka K; Yasuda T; Fujihara J; Toga T; Ono R; Otsuka Y; Ueki M; Iida R; Sano R; Nakajima T; Kominato Y; Kato H; Takeshita H
    Electrophoresis; 2012 Sep; 33(18):2852-8. PubMed ID: 23019102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.
    Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ
    Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex high-resolution linkage disequilibrium and haplotype patterns of single-nucleotide polymorphisms in 2.5 Mb of sequence on human chromosome 21.
    Olivier M; Bustos VI; Levy MR; Smick GA; Moreno I; Bushard JM; Almendras AA; Sheppard K; Zierten DL; Aggarwal A; Carlson CS; Foster BD; Vo N; Kelly L; Liu X; Cox DR
    Genomics; 2001 Nov; 78(1-2):64-72. PubMed ID: 11707074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of human UDP-Glucuronosyltransferase 2B7 gene expression by cytotoxic anticancer drugs in liver cancer HepG2 cells.
    Hu DG; Mackenzie PI; Lu L; Meech R; McKinnon RA
    Drug Metab Dispos; 2015 May; 43(5):660-8. PubMed ID: 25713207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of UGT2B7 is driven by two mutually exclusive promoters and alternative splicing in human tissues: changes from prenatal life to adulthood and in kidney cancer.
    Ménard V; Lévesque E; Chen S; Eap O; Joy MS; Ekström L; Rane A; Guillemette C
    Pharmacogenet Genomics; 2013 Dec; 23(12):684-96. PubMed ID: 24128937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.